Struggling DNA testing firm 23andMe to be bought for $256m
Source: BBC
Lily JamaliReporting fromSan Francisco, CAReutersThe DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).It comes two months after the company filed for bankruptcy protection in the US.23andMe said Regeneron had committed to comply with its privacy policies as part of the deal, and that Regeneron has security controls in place to protect…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC